$370 Million is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 23.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP | $59,307,000 | +10.8% | 505,299 | +2.8% | 16.03% | -11.4% |
| MCK | Buy | MCKESSON CORP | $48,188,000 | +7.0% | 411,655 | +1.0% | 13.02% | -14.3% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $45,472,000 | +20.0% | 476,042 | -11.0% | 12.29% | -3.9% |
| BIIB | New | BIOGEN INC | $42,548,000 | – | 180,000 | +100.0% | 11.50% | – |
| AMGN | Buy | AMGEN INC | $36,793,000 | +6.0% | 193,670 | +8.6% | 9.94% | -15.2% |
| GILD | Buy | GILEAD SCIENCES INC | $36,329,000 | +9.4% | 558,827 | +5.3% | 9.82% | -12.4% |
| MRK | Sell | MERCK & CO. INC | $34,333,000 | +4.5% | 412,809 | -4.0% | 9.28% | -16.4% |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $28,998,000 | +357.7% | 904,202 | +349.9% | 7.84% | +266.3% |
| RTIX | Sell | RTI SURGICAL HDS INC | $23,872,000 | +45.2% | 3,971,997 | -10.6% | 6.45% | +16.2% |
| IVC | Buy | INVACARE CORP | $11,297,000 | +97.5% | 1,349,741 | +1.5% | 3.05% | +58.1% |
| AVNS | Sell | AVANOS MEDICAL INC | $2,649,000 | -8.3% | 62,057 | -3.8% | 0.72% | -26.6% |
| DRAD | Sell | DIGIRAD CORP | $269,000 | +43.1% | 295,168 | -10.5% | 0.07% | +15.9% |
| OFIX | Exit | ORTHOFIX MEDICAL INC | $0 | – | -56,664 | -100.0% | -1.00% | – |
| SHPG | Exit | SHIRE PLC | $0 | – | -140,157 | -100.0% | -8.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.